Fundies. English
Segment disclosures
Company overviewINTREXON CORP
Each reported dimension combination stays separate. Revenue and operating income are shown as reported, with their dates and sources.
Revenue · Reported segment facts
47 dimension combinations 459 retained observations 32 reported periods
Counts describe retained dimensioned rows only. Periods and members can change across reports, and this view does not infer missing values or expected segment totals.
Intersegment Elimination · Acto Bio
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:ActoBioMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | -3000 | USD | 20210301 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 498000 | USD | 20210301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 840000 | USD | 20210301 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 1183000 | USD | 20200302 | Open filing evidence |
Intersegment Elimination · Biopharmaceuticals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:BiopharmaceuticalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 1446000 | USD | 20230306 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 1446000 | USD | 20220808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1446000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 1637000 | USD | 20230306 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 87000 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 328000 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 241000 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 4797000 | USD | 20230306 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1513000 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 3602000 | USD | 20210809 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 12908000 | USD | 20220301 | Open filing evidence |
Intersegment Elimination · Exemplar Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:ExemplarSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 0 | USD | 20230306 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20220808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 0 | USD | 20230306 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 0 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 0 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20210510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 0 | USD | 20230306 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 7000 | USD | 20220301 | Open filing evidence |
Intersegment Elimination · Human Biotherapeutics Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:HumanBiotherapeuticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 0 | USD | 20210301 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 0 | USD | 20210301 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20210301 | Open filing evidence |
Intersegment Elimination · MBP Titan Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:MBPTitanSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 7000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 7000 | USD | 20200511 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 0 | USD | 20200511 | Open filing evidence |
Intersegment Elimination · Methane Bioconversion Platform Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:MethaneBioconversionPlatformSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 96000 | USD | 20200302 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 9000 | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 0 | USD | 20200302 | Open filing evidence |
Intersegment Elimination · PGEN Therapeutics Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PGENTherapeuticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 5006000 | USD | 20210301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1992000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 5707000 | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1612000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 3715000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2103000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 11341000 | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2313000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 7090000 | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2412000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4777000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 2365000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 617000 | USD | 20210301 | Open filing evidence |
Intersegment Elimination · Precigen Acto Bio Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PrecigenActoBioSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-03-31 | 0 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 443000 | USD | 20200511 | Open filing evidence |
Intersegment Elimination · Precigen Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PrecigenSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 11341000 | USD | 20200302 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 617000 | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 0 | USD | 20200302 | Open filing evidence |
Intersegment Elimination · Trans Ova Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=pgen:TransOvaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 147000 | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 429000 | USD | 20220301 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 126000 | USD | 20211108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 324000 | USD | 20211108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 91000 | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 198000 | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 107000 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 340000 | USD | 20220301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 55000 | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 254000 | USD | 20211108 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 90000 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 199000 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 109000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1361000 | USD | 20220301 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 674000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 947000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 273000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 558000 | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 243000 | USD | 20200302 | Open filing evidence |
Intersegment Elimination · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 281000 | USD | 20210301 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 281000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 11000 Restated | USD | 20220301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 78000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 646000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 112000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 568000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 13000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 255000 | USD | 20210301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 120000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 847000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 265000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 720000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 630000 | USD | 20200302 | Open filing evidence |
Intersegment Elimination · Fine Chemicals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=xon:FineChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 1225000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 4090000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1371000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2865000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 1160000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 3954000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1295000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2794000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Intersegment Elimination · Methane Bioconversion Platform Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=xon:MethaneBioconversionPlatformSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 0 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 2000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 8000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 4000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 6000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Intersegment Elimination · Okanagan Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=xon:OkanaganSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 0 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 0 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 0 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 0 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 0 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Intersegment Elimination · Precigen Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=xon:PrecigenSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 2313000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 7090000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2412000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4777000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 200000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 431000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 110000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 231000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Intersegment Elimination · Trans Ova Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember;us-gaap:StatementBusinessSegmentsAxis=xon:TransOvaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 257000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1204000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 674000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 947000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 136000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 382000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 77000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 92000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Operating Segments · Acto Bio
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:ActoBioMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 3050000 Restated | USD | 20210301 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 134000 Restated | USD | 20210301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 7524000 Restated | USD | 20210301 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 14112000 Restated | USD | 20200302 | Open filing evidence |
Operating Segments · Biopharmaceuticals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:BiopharmaceuticalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 1341000 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 0 | USD | 20250319 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 75000 | USD | 20250319 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 0 | USD | 20231109 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 0 | USD | 20231109 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 14894000 | USD | 20250319 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 14624000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 14778000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 70000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 154000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1530000 Restated | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 922000 | USD | 20240319 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1270000 Restated | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 2192000 Restated | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 503000 Restated | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 922000 Restated | USD | 20220808 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 26577000 Restated | USD | 20220301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 7300000 Restated | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 26224000 Restated | USD | 20211108 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 5973000 Restated | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 18924000 Restated | USD | 20210809 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 19167000 Restated | USD | 20220301 | Open filing evidence |
Operating Segments · Exemplar Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:ExemplarSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-03-31 | 1065000 | USD | 20250514 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3925000 | USD | 20250319 | Open filing evidence |
| 2024-07-01 – 2024-09-30 | 953000 | USD | 20241114 | Open filing evidence |
| 2024-01-01 – 2024-09-30 | 2735000 | USD | 20241114 | Open filing evidence |
| 2024-04-01 – 2024-06-30 | 717000 | USD | 20240814 | Open filing evidence |
| 2024-01-01 – 2024-06-30 | 1782000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6150000 | USD | 20250319 | Open filing evidence |
| 2023-07-01 – 2023-09-30 | 1379000 | USD | 20241114 | Open filing evidence |
| 2023-01-01 – 2023-09-30 | 4997000 | USD | 20241114 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1767000 | USD | 20240814 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3618000 | USD | 20240814 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12015000 | USD | 20250319 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 2098000 | USD | 20231109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 10368000 | USD | 20231109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2841000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 8270000 | USD | 20230809 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 13345000 | USD | 20220301 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 3204000 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 9860000 | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 3399000 | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 6656000 | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 3257000 | USD | 20210510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 10158000 | USD | 20220301 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 2105000 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4256000 | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2151000 | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 6965000 Restated | USD | 20220301 | Open filing evidence |
Operating Segments · Human Biotherapeutics Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:HumanBiotherapeuticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 17810000 | USD | 20210301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2394000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 16967000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 10363000 | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 3713000 | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 402000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3247000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 383000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 0 | USD | 20210301 | Open filing evidence |
Operating Segments · MBP Titan Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:MBPTitanSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 7000 Restated | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 7000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 7000 Restated | USD | 20200511 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 1117000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3815000 Restated | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1217000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2698000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 1481000 | USD | 20200511 | Open filing evidence |
Operating Segments · Methane Bioconversion Platform Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:MethaneBioconversionPlatformSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 3909000 Restated | USD | 20200302 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 9936000 Restated | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 14336000 | USD | 20200302 | Open filing evidence |
Operating Segments · PGEN Therapeutics Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PGENTherapeuticsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 5782000 Restated | USD | 20210301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2156000 Restated | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 6249000 Restated | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 1830000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4093000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2263000 Restated | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13568000 Restated | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2757000 Restated | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 9264000 Restated | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2961000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 6507000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 3546000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 29638000 Restated | USD | 20210301 | Open filing evidence |
Operating Segments · Precigen Acto Bio Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PrecigenActoBioSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 2823000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 3050000 Restated | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 29000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 227000 Restated | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 198000 | USD | 20200511 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 237000 Restated | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1314000 Restated | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 233000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 1077000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 844000 Restated | USD | 20200511 | Open filing evidence |
Operating Segments · Precigen Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:PrecigenSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-01-01 – 2019-12-31 | 13568000 Restated | USD | 20200302 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 29638000 Restated | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 53184000 | USD | 20200302 | Open filing evidence |
Operating Segments · Trans Ova Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=pgen:TransOvaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-03-31 | 26655000 Restated | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 90035000 Restated | USD | 20220301 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 18354000 Restated | USD | 20211108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 69393000 Restated | USD | 20211108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 29856000 Restated | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 51039000 Restated | USD | 20210809 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 21183000 Restated | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 71526000 Restated | USD | 20220301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 15283000 Restated | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 56112000 Restated | USD | 20211108 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 23935000 Restated | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 40829000 Restated | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 16894000 Restated | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 70033000 Restated | USD | 20220301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 14238000 Restated | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 54511000 Restated | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 25066000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 40273000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 15207000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 75736000 Restated | USD | 20200302 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 80026000 Restated | USD | 20200302 | Open filing evidence |
Operating Segments · All Other Segments
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-01-01 – 2020-12-31 | 10580000 Restated | USD | 20210301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2974000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 7652000 Restated | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2573000 Restated | USD | 20200511 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 13784000 Restated | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 2196000 Restated | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 10364000 Restated | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 8704000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 13961000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 4110000 Restated | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 30468000 Restated | USD | 20210301 | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 6891000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 27075000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 9621000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 20184000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 59804000 Restated | USD | 20200302 | Open filing evidence |
Operating Segments · Fine Chemicals Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=xon:FineChemicalsSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 3402000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 8257000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2551000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 4855000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2263000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 8165000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 2721000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 5902000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Operating Segments · Methane Bioconversion Platform Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=xon:MethaneBioconversionPlatformSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 1117000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 3815000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 1217000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2698000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 2085000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 5038000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 1375000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 2953000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Operating Segments · Okanagan Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=xon:OkanaganSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 6000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 45000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 19000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 39000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 10000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 37000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 20000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 27000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Operating Segments · Precigen Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=xon:PrecigenSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 2757000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 9264000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2961000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 6507000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 7022000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 22716000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 7442000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 15694000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Operating Segments · Trans Ova Segment
Consolidation Items · Statement Business Segments
Source dimensions
srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember;us-gaap:StatementBusinessSegmentsAxis=xon:TransOvaSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 14238000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 54511000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 25066000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 40273000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 15770000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 59849000 Restated | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 25857000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 44079000 Restated | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
Biopharmaceuticals Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:BiopharmaceuticalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 1446000 | USD | 20221109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 1141000 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 1469000 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 241000 | USD | 20210510 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 1919000 | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 5521000 | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 2089000 | USD | 20210510 | Open filing evidence |
Biopharmaceuticals Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:BiopharmaceuticalsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2022-01-01 – 2022-12-31 | 16340000 Restated | USD | 20230306 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 1530000 Restated | USD | 20220509 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 2559000 Restated | USD | 20230306 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 419000 Restated | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 26577000 Restated | USD | 20230306 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 12951000 Restated | USD | 20210510 | Open filing evidence |
Exemplar Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:ExemplarSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-04-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 0 | USD | 20230510 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 0 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 0 | USD | 20221109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 0 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 0 | USD | 20230510 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 0 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 0 | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 0 | USD | 20220509 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 0 | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20211108 | Open filing evidence |
Exemplar Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:ExemplarSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2024-01-01 – 2024-03-31 | 1065000 | USD | 20240514 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6150000 | USD | 20240319 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1851000 | USD | 20240514 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 12015000 | USD | 20240319 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2841000 | USD | 20220808 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 8270000 | USD | 20220808 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 5429000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 13345000 | USD | 20240319 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 3204000 | USD | 20211108 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 9860000 | USD | 20211108 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 3399000 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 6656000 | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 3257000 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 10158000 | USD | 20230306 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 2974000 | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 7230000 | USD | 20211108 | Open filing evidence |
Human Biotherapeutics Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:HumanBiotherapeuticsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 0 | USD | 20200810 | Open filing evidence |
Human Biotherapeutics Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:HumanBiotherapeuticsSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 4210000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 14573000 | USD | 20200810 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2462000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2845000 | USD | 20200810 | Open filing evidence |
MBP Titan Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:MBPTitanSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 7000 | USD | 20200810 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 2000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 2000 | USD | 20200810 | Open filing evidence |
Precigen Acto Bio Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:PrecigenActoBioSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | -3000 | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | -3000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | -3000 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 6000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 501000 | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 52000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 495000 | USD | 20200810 | Open filing evidence |
Reportable Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:ReportableSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2026-04-01 – 2026-06-30 | 54978000 | USD | 20260804 | Open filing evidence |
| 2026-01-01 – 2026-06-30 | 78230000 | USD | 20260804 | Open filing evidence |
| 2025-04-01 – 2025-06-30 | 856000 | USD | 20260804 | Open filing evidence |
| 2025-01-01 – 2025-06-30 | 2197000 | USD | 20260804 | Open filing evidence |
| 2023-04-01 – 2023-06-30 | 1767000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-06-30 | 3618000 | USD | 20230809 | Open filing evidence |
| 2023-01-01 – 2023-03-31 | 1851000 | USD | 20230510 | Open filing evidence |
| 2022-01-01 – 2022-12-31 | 28355000 | USD | 20230306 | Open filing evidence |
| 2022-07-01 – 2022-09-30 | 16722000 | USD | 20221109 | Open filing evidence |
| 2022-01-01 – 2022-09-30 | 26592000 | USD | 20221109 | Open filing evidence |
| 2022-04-01 – 2022-06-30 | 2911000 | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-06-30 | 8424000 Restated | USD | 20230809 | Open filing evidence |
| 2022-01-01 – 2022-03-31 | 6959000 Restated | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-12-31 | 15904000 Restated | USD | 20230306 | Open filing evidence |
| 2021-07-01 – 2021-09-30 | 4474000 Restated | USD | 20221109 | Open filing evidence |
| 2021-01-01 – 2021-09-30 | 12052000 Restated | USD | 20221109 | Open filing evidence |
| 2021-04-01 – 2021-06-30 | 3902000 Restated | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-06-30 | 7578000 Restated | USD | 20220808 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 24859000 | USD | 20220509 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 36735000 Restated | USD | 20230306 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 25557000 Restated | USD | 20211108 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 89566000 Restated | USD | 20211108 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 32013000 Restated | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 64009000 Restated | USD | 20210809 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 31996000 Restated | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 96165000 Restated | USD | 20220301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 18751000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 72151000 | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 31939000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 53400000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-03-31 | 21461000 | USD | 20200511 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 112898000 Restated | USD | 20210301 | Open filing evidence |
| 2017-01-01 – 2017-12-31 | 161658000 | USD | 20200302 | Open filing evidence |
Trans Ova Segment · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:TransOvaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2021-01-01 – 2021-03-31 | 107000 | USD | 20210510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 340000 | USD | 20210301 | Open filing evidence |
| 2020-07-01 – 2020-09-30 | 55000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 254000 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 109000 | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 1361000 | USD | 20210301 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 257000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 1204000 | USD | 20201109 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 558000 | USD | 20210301 | Open filing evidence |
Trans Ova Segment · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=pgen:TransOvaSegmentMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2023-01-01 – 2023-03-31 | 1851000 | USD | 20230510 | Open filing evidence |
| 2021-01-01 – 2021-03-31 | 21183000 Restated | USD | 20210510 | Open filing evidence |
| 2020-01-01 – 2020-12-31 | 71526000 Restated | USD | 20210301 | Open filing evidence |
| 2020-01-01 – 2020-03-31 | 16894000 Restated | USD | 20210510 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 70033000 Restated | USD | 20210301 | Open filing evidence |
| 2018-01-01 – 2018-12-31 | 75736000 Restated | USD | 20210301 | Open filing evidence |
All Other Segments · Intersegment Elimination
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:IntersegmentEliminationMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-07-01 – 2020-09-30 | 0 | USD | 20201109 | Open filing evidence |
| 2020-01-01 – 2020-09-30 | 281000 | USD | 20201109 | Open filing evidence |
| 2020-04-01 – 2020-06-30 | 0 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 281000 | USD | 20200810 | Open filing evidence |
| 2019-07-01 – 2019-09-30 | 72000 | USD | 20201109 | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 145000 | USD | 20201109 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 60000 | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 73000 | USD | 20200810 | Open filing evidence |
All Other Segments · Operating Segments
Statement Business Segments · Consolidation Items
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:AllOtherSegmentsMember;srt:ConsolidationItemsAxis=us-gaap:OperatingSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2020-04-01 – 2020-06-30 | 2105000 | USD | 20200810 | Open filing evidence |
| 2020-01-01 – 2020-06-30 | 4678000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-12-31 | 4884000 Restated | USD | 20220301 | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 4058000 Restated | USD | 20200810 | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 8168000 Restated | USD | 20200810 | Open filing evidence |
Reportable Segment Aggregation Before Other Operating Segment
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=us-gaap:ReportableSegmentAggregationBeforeOtherOperatingSegmentMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2025-01-01 – 2025-12-31 | 9684000 | USD | 20260325 | Open filing evidence |
| 2024-01-01 – 2024-12-31 | 3925000 | USD | 20260325 | Open filing evidence |
| 2023-01-01 – 2023-12-31 | 6225000 | USD | 20260325 | Open filing evidence |
Reportable Segments
Statement Business Segments
Source dimensions
us-gaap:StatementBusinessSegmentsAxis=xon:ReportableSegmentsMember| Period | Value | Unit | Filed | Evidence |
|---|---|---|---|---|
| 2019-07-01 – 2019-09-30 | 21520000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-01-01 – 2019-09-30 | 75892000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2019-04-01 – 2019-06-30 | 31814000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2019-01-01 – 2019-06-30 | 54372000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-07-01 – 2018-09-30 | 27150000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-01-01 – 2018-09-30 | 95805000 | USD | 2019-11-12 · 12:55:59.000Z | Open filing evidence |
| 2018-04-01 – 2018-06-30 | 37415000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |
| 2018-01-01 – 2018-06-30 | 68655000 | USD | 2019-08-09 · 15:45:49.000Z | Open filing evidence |